SLNO Soleno Therapeutics, Inc. gains 19% Jun 26, 2018

Posted By: Rajesh Srivastava - Tuesday, June 26, 2018

Share

& Comment

Capnia, Inc. develops and commercializes therapeutics and diagnostics products. The company offers CoSense for the diagnosis of excessive hemolysis in neonates, a condition that causes long-term developmental disability due to degradation of red blood cells. It also develops Serenz, a therapeutic product candidate that has completed Phase II clinical trials for the treatment of symptoms related to allergic rhinitis. The company was founded in 1999 and is based in Redwood City, California.http://www.priceseries.com/trade/SLNO-Soleno-Therapeutics-Inc-stock-gains-19-percent-a-Trade-Record-by-priceSeries-2018061220180626.html

About Rajesh Srivastava

Techism is an online Publication that complies Bizarre, Odd, Strange, Out of box facts about the stuff going around in the world which you may find hard to believe and understand. The Main Purpose of this site is to bring reality with a taste of entertainment

0 comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Copyright © priceSeries Daily Results™ is a registered trademark.

Designed by Templateism. Hosted on Blogger Platform.